4.7 Article

Genetic variants associated with circulating C-reactive protein levels and colorectal cancer survival: Sex-specific and lifestyle factors specific associations

期刊

INTERNATIONAL JOURNAL OF CANCER
卷 150, 期 9, 页码 1447-1454

出版社

WILEY
DOI: 10.1002/ijc.33897

关键词

colorectal cancer; C-reactive protein; genetic variants; survival

类别

资金

  1. ISACC: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [R01 CA176272]
  2. NIH/NCI Cancer Center Support Grant [P30 CA015704]
  3. ORIP grant [S10OD028685]
  4. National Cancer Institute (NCI), National Institutes of Health (NIH) [U01 CA167551]
  5. Surveillance, Epidemiology and End Results (SEER) Program
  6. Victoria Cancer Registry (Australia)
  7. Ontario Cancer Registry (Canada)
  8. NIH [U01 CA122839, R01 CA143247, U19 CA148107, R01 CA81488, U01 HG004446, GEI U01 HG 004438]
  9. Center for Inherited Disease Research (CIDR) - NIH [HHSN268201200008I]
  10. Ontario Research Fund [GL201-043]
  11. Canadian Institutes of Health Research [112746]
  12. Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society
  13. Ontario Ministry of Research and Innovation
  14. NCI/NIH [U01/U24 CA074794, R01 CA076366]
  15. German Research Council [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1, HO 5117/2-1, HE 5998/2-1, KL 2354/3-1, RO 2270/8-1, BR 1704/17-1]
  16. Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany
  17. German Federal Ministry of Education and Research [01KH0404, 01ER0814, 01ER0815, 01ER1505A, 01ER1505B]
  18. DALS: National Institutes of Health [R01 CA048998]
  19. NCI, EDRN Grant [U01 CA 084968-06]
  20. International Agency for Research on Cancer (IARC)
  21. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
  22. Danish Cancer Society (Denmark)
  23. Ligue Contre le Cancer (France)
  24. Institut Gustave Roussy (France)
  25. Mutuelle Generale de l'Education Nationale (France)
  26. Institut National de la Sante et de la Recherche Medicale (INSERM) (France)
  27. German Cancer Aid (Germany)
  28. German Cancer Research Center (DKFZ) (Germany)
  29. German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) (Germany)
  30. Federal Ministry of Education and Research (BMBF) (Germany)
  31. Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy (Italy)
  32. Compagnia di SanPaolo (Italy)
  33. National Research Council (Italy)
  34. Dutch Ministry of Public Health, Welfare and Sports (VWS) (The Netherlands)
  35. Netherlands Cancer Registry (NKR) (The Netherlands)
  36. LK Research Funds (The Netherlands)
  37. Dutch Prevention Funds (The Netherlands)
  38. Dutch ZON (Zorg Onderzoek Nederland)
  39. World Cancer Research Fund (WCRF) (The Netherlands)
  40. Statistics Netherlands (The Netherlands)
  41. Health Research Fund (FIS) -Instituto de Salud Carlos III (ISCIII) (Spain)
  42. Regional Government of Andalucia (Spain)
  43. Regional Government of Asturias (Spain)
  44. Regional Government of Basque Country (Spain)
  45. Regional Government of Murcia (Spain)
  46. Regional Government of Navarra (Spain)
  47. Catalan Institute of Oncology-ICO (Spain)
  48. Swedish Cancer Society (Sweden)
  49. Swedish Research Council (Sweden)
  50. County Council of Skane (Sweden)
  51. County Council of Vasterbotten (Sweden)
  52. Cancer Research UK [14136, C8221/A29017]
  53. Medical Research Council (United Kingdom) [1000143, MR/M012190/1]
  54. National Institutes of Health [P01 CA055075, UM1 CA167552, U01 CA167552, R01 CA137178, R01 CA151993, R35 CA197735, P01 CA087969, UM1 CA186107, R01 CA042182, K05 CA154337]
  55. VicHealth
  56. Cancer Council Victoria
  57. Australian NHMRC [509348, 209057, 251553, 504711]
  58. Division of Cancer Prevention, National Cancer Institute, NIH, DHHS
  59. National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) [Z01 CP 010200]
  60. National Heart, Lung and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]

向作者/读者索取更多资源

Elevated levels of C-reactive protein (CRP) in the blood have been associated with colorectal cancer (CRC) survival. This study examined the genetic variants associated with CRP levels and their interactions with sex and lifestyle factors in relation to CRC-specific mortality. The results showed a significant interaction between a genetic variant and sex in determining CRC-specific mortality.
Elevated blood levels of C-reactive protein (CRP) have been linked to colorectal cancer (CRC) survival. We evaluated genetic variants associated with CRP levels and their interactions with sex and lifestyle factors in association with CRC-specific mortality. Our study included 16 142 CRC cases from the International Survival Analysis in Colorectal Cancer Consortium. We identified 618 common single nucleotide polymorphisms (SNPs) associated with CRP levels from the NHGRI-EBI GWAS Catalog. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between SNPs and CRC-specific mortality adjusting for age, sex, genotyping platform/study and principal components. We investigated their interactions with sex and lifestyle factors using likelihood ratio tests. Of 5472 (33.9%) deaths accrued over up to 10 years of follow-up, 3547 (64.8%) were due to CRC. No variants were associated with CRC-specific mortality after multiple comparison correction. We observed strong evidence of interaction between variant rs1933736 at FRK gene and sex in relation to CRC-specific mortality (corrected P-interaction = .0004); women had higher CRC-specific mortality associated with the minor allele (HR = 1.11, 95% CI = 1.04-1.19) whereas an inverse association was observed for men (HR = 0.88, 95% CI = 0.82-0.94). There was no evidence of interactions between CRP-associated SNPs and alcohol, obesity or smoking. Our study observed a significant interaction between sex and a CRP-associated variant in relation to CRC-specific mortality. Future replication of this association and functional annotation of the variant are needed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据